← All businessesHealthcare & Life Sciences / Pharmacies / Online pharmacy
Online Pharmacy Selling UK-Wide From A Leeds Base
Leeds, West Yorkshire, Yorkshire & the HumberIdentity protected
Available
About this business
An online pharmacy run from Leeds, selling prescription and over-the-counter treatments to customers across the UK through its own website. Turnover has grown gently from £4.31m in 2021 to £4.7m, but EBITDA has eased back from a peak of £1.22m in 2022 to £996k, something a buyer will want to understand during due diligence. Even so, the margin is healthy at about 21%. A team of 14 covers pharmacists, dispatch and customer care. There is no property in the sale, and the asking price of £4.7m sits at roughly the level of a single year's sales.
Key investment highlights
- EBITDA of £996k on £4.7m turnover
- Sales higher than in 2021
- Team of 14, no premises
- Customers ordering from across the UK
Reason for sale
The founders are going separate ways and have agreed to sell rather than split the business.
Nothing flagged on the two questions buyers ask first
No flagRevenue going backwards and one client being too much of it are the two things that end most deals in due diligence. Both are shown here up front, from the figures the seller supplied.
- Revenue directionNo flag
Turnover is flat year on year.
- 2021: baseline
- 2022 (+3.1%)
- 2023 (-0.8%)
- 2024 (+2.7%)
- 2025 (+1.7%)
- 2026 (+2.0%)
6 years of turnover, 2021 to 2026, as supplied by the seller.
- Client concentrationNot stated
The seller has not declared what share of revenue the largest clients represent.
No declaration supplied. Client concentration cannot be derived from accounts.
EBITDA margin narrowed from 27.5% in 2021 to 21.2% in 2026.
These are observations from the supplied figures, not a view on whether this business is worth buying. Nothing here predicts an outcome.
Computing valuation...
What happens next
Submit an enquiry to the seller. Once they approve it, you sign a non-disclosure agreement and gain access to the information memorandum, the financials and a secure deal room with the seller.